UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-A

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR (g) OF THE
SECURITIES EXCHANGE ACT OF 1934

ENDOCARE, INC.

(Exact name of registrant as specified in its charter)

Delaware		33-0618093
(State of incorporation or organization)		(I.R.S. Employer Identification No.)
201 Technology Drive, Irvine, California		92618
(Address of principal executive offices)		(Zip Code)

Securities to be registered pursuant to Section 12(b) of the Act:

Title of each class to be so registered		Name of each exchange on which each class is to be registered
Common Stock, $0.001 par value per share		The NASDAQ Stock Market LLC
Preferred Stock Purchase Rights		The NASDAQ Stock Market LLC

     If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), check the following box. x

     If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), check the following box. o

     Securities Act registration statement file number to which this form relates:
____________________(if applicable)

     Securities to be registered pursuant to Section 12(g) of the Act:

NONE

Title of Class

 

 

Item 1. Description of Registrant’s Securities to Be Registered.

     A description of the common stock, par value $0.001 per share, of Endocare, Inc., a Delaware corporation (the “Registrant”), that is registered hereunder is provided under the caption “Description of Capital Stock” in the Registrant’s Form 10-SB initially filed with the Securities and Exchange Commission (the “Commission”) on November 14, 1995 (the “Form 10-SB”). A description of the preferred stock purchase rights of the Registrant that is registered hereunder is provided under the caption “Description of Registrant’s Securities to Be Registered” in the Registrant’s Form 8-A filed with the Commission on June 28, 2005 (the “Form 8-A”). Such portions of the Form 10-SB and Form 8-A are incorporated herein by reference.

Item 2. Exhibits.

Pursuant to the “Instructions as to Exhibits” in Form 8-A, no exhibits are filed herein.

SIGNATURE

     Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.